Dyadic raises $2.9M for working capital
In Florida, biotech company Dyadic International has entered into definitive agreements with an institutional investor to raise approximately $2.9 million through a registered direct offering of common stock and a concurrent private placement of warrants. The company will use the funds for general corporate purposes and working capital. The offering price per share of Common Stock is $0.795 and per Warrant is $0.005. The transactions consisted of the sale of 3,625,000 shares of Common Stock in the registered direct offering and Common Warrants to purchase 3,625,000 shares of Common Stock in the private placement with an exercise price of $0.84 per share. Dyadic develops recombinant protein solutions across the life sciences, food and nutrition, bio-industrial and biopharmaceutical markets.
Category: Chemicals & Materials
